Therapy News and Research

RSS

Study: sdNVP can lead to HIV treatment failure in women receiving drug to prevent infant infection

A new international study reported in PLoS Medicine confirms that a single dose of nevirapine (sdNVP) can lead to HIV treatment failure in women who receive the drug to prevent transmission of the AIDS virus to their infants. However, the increased risk of failure could only be detected in women who began full HIV treatment within about a year after receiving sdNVP.

16 Feb 2010

GSMA announces important updates to Embedded Mobile initiative

The GSMA today announced several important updates to its Embedded Mobile initiative, a programme to accelerate the global adoption of wireless connectivity in a wide range of devices in key vertical markets such as consumer electronics, healthcare, automotive and utilities.

16 Feb 2010

AstraZeneca, Rigel Pharmaceuticals announce exclusive worldwide license agreement for R788

AstraZeneca and Rigel Pharmaceuticals today announced an exclusive worldwide license agreement for the global development and commercialization of fostamatinib disodium (R788), Rigel's late-stage investigational product for rheumatoid arthritis (RA) and additional indications.

16 Feb 2010

Clive Svendsen to receive American Academy of Neurology Sheila Essey Award for his research on ALS

Clive Svendsen, Ph.D., director of the Cedars-Sinai Regenerative Medicine Institute, is receiving the American Academy of Neurology Sheila Essey Award for his research on ALS (amyothrophic lateral sclerosis).

16 Feb 2010

Teva Pharmaceutical Industries announces fourth-quarter and full-year 2009 financial results

Teva Pharmaceutical Industries Ltd. today reported record results for the quarter and year ended December 31, 2009.

16 Feb 2010

Nascent symptoms of autism in infants emerge during latter part of first year of life

A study of the development of autism in infants, comparing the behavior of the siblings of children diagnosed with autism to that of babies developing normally, has found that the nascent symptoms of the condition - a lack of shared eye contact, smiling and communicative babbling - are not present at 6 months, but emerge gradually and only become apparent during the latter part of the first year of life.

16 Feb 2010

NorTech announces winners of annual Innovation Awards program

NorTech, in partnership with Crain's Cleveland Business, is pleased to announce the winners of its annual Innovation Awards program which honors the achievements of Northeast Ohio's most innovative organizations and leaders.

16 Feb 2010

Children's Hospital of Philadelphia awarded two grants to research into cellular therapies for blood disorders

The new decade may herald an era of cell therapy -- treating human diseases by delivering highly specific beneficial cells. In the wake of an NIH decision late last year permitting federally funded researchers to use new lines of human embryonic stem cells, the door has opened more widely to stem cell research.

16 Feb 2010

Progressive walking reduces arthritic pain, improves physical function

"Progressive walking" combined with glucosamine sulphate supplementation has been shown to improve the symptoms of osteoarthritis. Researchers writing in BioMed Central's open-access journal Arthritis Research and Therapy found that patients who walked at least two bouts of 1500 steps each on three days of the week reported significantly less arthritis pain, and significantly improved physical function.

16 Feb 2010

Genous Bio-engineered R stent beneficial for patients not suitable for long term DAPT

OrbusNeich announced that clinical data presented at the Joint Intervention Meeting (JIM) 2010 in Rome provide further evidence that the company's Genous stent could be a treatment of choice for patients not suitable for long term dual antiplatelet therapy. The investigator initiated, 50 patient, multicenter study evaluated the safety of patients receiving only 10 days dual antiplatelet therapy undergoing stenting with the Genous Bio-engineered R stent. The primary endpoint was the absence of stent thrombosis or any occlusion within three months.

15 Feb 2010

American Showa joins with Concentra to open Showa Associates' Wellness Center in Ohio

For innovative employers, providing employee health coverage entails more than just offering health insurance, it becomes the focal point to improve the overall health of their employees and their families. American Showa, Inc., an auto parts manufacturer with two manufacturing plants in Ohio, is leading this effort by joining with Concentra to open the Showa Associates' Wellness Center, a new 4,000 sq ft medical center for their associates and their families located near their manufacturing facility in Blanchester, OH.

15 Feb 2010

Botulinum injection used for cosmetic purposes may reduce migraine headaches

A preliminary study suggests the same type of botulinum injection used for cosmetic purposes may be associated with reduced frequency of migraine headaches that are described as crushing, vicelike or eye-popping (ocular), but not pain that is experienced as a buildup of pressure inside the head, according to a report in the February issue of Archives of Dermatology, one of the JAMA/Archives journals.

15 Feb 2010

Stematix enters into 10-year exclusive agreement with Laboratorios Bagó SA

Stematix, Inc. (Houston, USA), a regenerative medicine provider positioned to accelerate safe and effective global use of stem cell therapies, announced today that it entered into a 10-year exclusive agreement with Laboratorios Bagó (Buenos Aires, Argentina), a leading Argentine medical products company.

15 Feb 2010

Muscle-preserving therapy development may help young men keep muscle shirts a bit longer

Hey guys, remember the muscle shirts we wore in our teens and 20s? After the age of 40 that meager part of our wardrobes usually is obsolete. Yes, at the big 4-0 we begin to lose muscle, and by age 80 up to a third of it may be gone. It's an inevitable process of aging called sarcopenia.

15 Feb 2010

Effective smoking cessation treatments

With the national trend toward quitting smoking flat, psychologists are finding some success with treatments aimed at helping smokers from underserved groups, including racial and ethnic minorities and those with psychiatric disorders.

15 Feb 2010

CROF, sanofi-aventis announce the creation of CASARIA for cancer research

The Canadian Radiation Oncology Foundation and sanofi-aventis are pleased to announce the creation of the Canadian Radiation Oncology Foundation/Sanofi-Aventis Research Innovation Award (CASARIA).

15 Feb 2010

Study shows severe OSA suppresses cognitive experience of nightmare recall

A study in the Feb. 15 issue of the Journal of Clinical Sleep Medicine shows that patients with severe obstructive sleep apnea (OSA) report a significantly lower frequency of nightmares than patients with mild or no sleep apnea, indicating that OSA suppresses the cognitive experience of nightmare recall.

15 Feb 2010

SRC-3 gene sends signal to cell membrane to promote cell motility

The master gene called SRC-3 (steroid receptor coactivator 3) not only enhances estrogen-dependent growth of cancer cells by activating and encouraging the transcription of a genetic message into a protein, it also sends a signal to the cell membrane to promote cell motility or movement - a key element of cancer spread or metastasis, said Baylor College of Medicine (www.bcm.edu) researchers and collaborators in a report that appears in the current issue of the journal Molecular Cell.

15 Feb 2010

Hypnosis has potential therapeutic value in children with respiratory disorders

Hypnosis has potential therapeutic value in children with respiratory disorders for alleviating symptoms such as habit cough or unexplained sensations of difficulty breathing and for lessening a child's discomfort during medical procedures.

15 Feb 2010

CoAxia completes enrollment in NeuroFlo Perfusion Augmentation Therapy trial for ischemic stroke

CoAxia™, Inc. of Maple Grove, MN, announced today the completion of enrollment in its SENTIS randomized, controlled, pivotal trial of NeuroFlo™ Perfusion Augmentation Therapy as an acute interventional treatment for ischemic stroke. The Company plans to complete data collection and analysis of results in Q3 of 2010 and, if warranted, submit a PMA to the US FDA.

15 Feb 2010

Therapy News and Research

Study: sdNVP can lead to HIV treatment failure in women receiving drug to prevent infant infection

GSMA announces important updates to Embedded Mobile initiative

AstraZeneca, Rigel Pharmaceuticals announce exclusive worldwide license agreement for R788

Clive Svendsen to receive American Academy of Neurology Sheila Essey Award for his research on ALS

Teva Pharmaceutical Industries announces fourth-quarter and full-year 2009 financial results

Nascent symptoms of autism in infants emerge during latter part of first year of life

NorTech announces winners of annual Innovation Awards program

Children's Hospital of Philadelphia awarded two grants to research into cellular therapies for blood disorders

Progressive walking reduces arthritic pain, improves physical function

Genous Bio-engineered R stent beneficial for patients not suitable for long term DAPT

American Showa joins with Concentra to open Showa Associates' Wellness Center in Ohio

Botulinum injection used for cosmetic purposes may reduce migraine headaches

Stematix enters into 10-year exclusive agreement with Laboratorios Bagó SA

Muscle-preserving therapy development may help young men keep muscle shirts a bit longer

Effective smoking cessation treatments

CROF, sanofi-aventis announce the creation of CASARIA for cancer research

Study shows severe OSA suppresses cognitive experience of nightmare recall

SRC-3 gene sends signal to cell membrane to promote cell motility

Hypnosis has potential therapeutic value in children with respiratory disorders

CoAxia completes enrollment in NeuroFlo Perfusion Augmentation Therapy trial for ischemic stroke

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News